文献速递系统性红斑狼疮

低密度粒细胞激活T细胞并在系统性红斑狼疮中发挥非抑制性作用

Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus.
PubMed 文献 · Ann Rheum Dis · 2019-04-30

该研究从健康供者和系统性红斑狼疮(SLE)患者新鲜血液中分离低密度粒细胞(LDG)与正常密度粒细胞(NDG),分析LDG与临床表现的关联,并通过多色流式细胞术和共聚焦成像进行免疫表型分析,量化其抑制T细胞功能及诱导细胞因子产生的能力。结果显示SLE患者LDG患病率升高,与干扰素21基因签名及疾病活动度相关,LDG与淋巴细胞比值较中性粒细胞与淋巴细胞比值与SLE疾病活动指数关联更好;SLE LDG表面活化标志物及凝集素样氧化低密度脂蛋白受体-1表达显著增高,其上清不能以精氨酸酶依赖方式限制健康供者CD4+ T细胞增殖,提示LDG不具免疫抑制性,且SLE LDG上清可诱导CD4+ T细胞产生促炎细胞因子(IFN gamma、肿瘤坏死因子alpha和淋巴毒素alpha)。结论认为SLE LDG呈活化表型,对T细胞发挥促炎效应,不具MDSC功能,支持LDG是SLE中具有致病潜能的独特促炎亚群这一概念,至少部分通过激活1型辅助应答实现。

要点

  • SLE患者LDG患病率升高,与干扰素21基因签名及疾病活动度相关。
  • LDG与淋巴细胞比值较中性粒细胞与淋巴细胞比值与SLE疾病活动指数关联更好。
  • SLE LDG不具免疫抑制性,其上清可诱导CD4+ T细胞产生促炎细胞因子。

核心结论

  • SLE LDG呈活化表型,对T细胞发挥促炎效应,不具MDSC功能,支持LDG是SLE中具有致病潜能的独特促炎亚群。

研究设计与样本

  • 从健康供者和SLE患者新鲜血液中分离LDG与NDG,分析LDG与临床表现的关联,并用多色流式细胞术和共聚焦成像进行免疫表型分析。
  • 量化LDG与NDG抑制T细胞功能及诱导细胞因子产生的能力。

主要发现

  • SLE患者LDG患病率较健康供者升高,与干扰素21基因签名及疾病活动度相关。
  • LDG与淋巴细胞比值较中性粒细胞与淋巴细胞比值与SLE疾病活动指数关联更好。
  • SLE LDG表面多种活化标志物及凝集素样氧化低密度脂蛋白受体-1表达显著增高。
  • SLE LDG上清不能以精氨酸酶依赖方式限制健康供者CD4+ T细胞增殖,提示LDG不具免疫抑制性。
  • SLE LDG上清可诱导CD4+ T细胞产生IFN gamma、肿瘤坏死因子alpha和淋巴毒素alpha等促炎细胞因子。

临床怎么用

  • LDG与淋巴细胞比值可能较中性粒细胞与淋巴细胞比值更好地反映SLE疾病活动度。
  • SLE中LDG为促炎亚群而非免疫抑制性MDSC,靶向其促炎作用或为潜在治疗方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The presence of proinflammatory low-density granulocytes (LDG) has been demonstrated in autoimmune and infectious diseases. Recently, regulatory neutrophilic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) were identified in systemic lupus erythematosus (SLE). Because LDG and PMN-MDSC share a similar phenotype with contrasting functional effects, we explored these cells in a cohort of patients with SLE. METHODS: LDG and normal-density granulocytes (NDG) were isolated from fresh blood of healthy donors (HD) and patients with SLE. Associations between LDG and clinical manifestations were analysed. Multicolor flow cytometry and confocal imaging were performed to immunophenotype the cells. The ability of LDG and NDG to suppress T cell function and induce cytokine production was quantified. RESULTS: LDG prevalence was elevated in SLE versus HD, associated with the interferon (IFN) 21-gene signature and disease activity. Also, the LDG-to-lymphocyte ratio associated better with SLE disease activity index than neutrophil-to-lymphocyte ratio. SLE LDG exhibited significantly heightened surface expression of various activation markers and also of lectin-like oxidised low-density lipoprotein receptor-1, previously described to be associated with PMN-MDSC. Supernatants from SLE LDG did not restrict HD CD4+ T cell proliferation in an arginase-dependent manner, suggesting LDG are not immunosuppressive. SLE LDG supernatants induced proinflammatory cytokine production (IFN gamma, tumour necrosis factor alpha and lymphotoxin alpha) from CD4+ T cells. CONCLUSIONS: Based on our results, SLE LDG display an activated phenotype, exert proinflammatory effects on T cells and do not exhibit MDSC function. These results support the concept that LDG represent a distinct proinflammatory subset in SLE with pathogenic potential, at least in part, through their ability to activate type 1 helper responses.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Rahman S, Sagar D, Hanna RN, et al. Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus. Ann Rheum Dis. 2019. PMID: 31040119. doi:10.1136/annrheumdis-2018-214620

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。